Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-γ-induced IκB degradation in RAW264.7 macrophages

Cancer Letters

Volumn 195, Issue 1, 2003, Pages 17-25

  Murakami, Akira ^a   Matsumoto, Kazuhiko ^b   Koshimizu, Koichi ^b   Ohigashi, Hajime ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

1 acetoxycahvicol acetate; Benzylisothiocyanate; Genistein; Nuclear factor kappaB; Zerumbone

Indexed keywords

1' ACETOXYCHAVICOL ACETATE; AURAPTENE; BENZYL ISOTHIOCYANATE; CHEMOPREVENTIVE AGENT; CYCLOOXYGENASE 2; DRUG; GAMMA INTERFERON; GENISTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; NOBILETIN; RESVERATROL; SYNAPTOTAGMIN; UNCLASSIFIED DRUG; ZERUMBONE;

ANIMAL CELL; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

MURINAE;

EID: 0038059372     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00058-2     Document Type: Article

References (53)

1. Shacter E., Weitzman S.A. Chronic inflammation and cancer. Oncology. 16:2002;217-226.
2. Peto J. Cancer epidemiology in the last century and the next decade. Nature. 411:2001;390-395.
3. Montalto G., Cervello M., Giannitrapani L., Dantona F., Terranova A., Castagnetta L.A. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann. NY Acad. Sci. 963:2002;13-20.
4. Lax A.J., Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol. 10:2002;293-299.
5. Ebert M.P., Schandl L., Malfertheiner P. Helicobacter pylori infection and molecular changes in gastric carcinogenesis. J. Gastroenterol. 37 (Suppl). 13:2002;45-49.
6. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480-481:2001;243-268.
7. Lappas M., Permezel M., Georgiou H.M., Rice G.E. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol. Reprod. 67:2002;668-673.
8. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:1998;225-260.
9. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 109:2002;S81-S96.
10. Pando M.P., Verma I.M. Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha. J. Biol. Chem. 275:2000;21278-21286.
11. Murakami A., Toyota K., Ohura S., Koshimizu K., Ohigashi H. Structure-activity relationships of (1′S)-1′-acetoxychavicol acetate, a major constituent of a southeast Asian condiment plant Languas galanga, on the inhibition of tumor-promoter-induced Epstein-Barr virus activation. J. Agric. Food Chem. 48:2000;1518-1523.
12. Murakami A., Takahashi M., Jiwajinda S., Koshimizu K., Ohigashi H. Identification of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation. Biosci. Biotechnol. Biochem. 63:1999;1811-1812.
13. Murakami A., Kuki W., Takahashi Y., Yonei H., Nakamura Y., Ohto Y., Ohigashi H., Koshimizu K. Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes. Jpn. J. Cancer Res. 88:1997;443-452.
14. Murakami A., Nakamura Y., Torikai K., Tanaka T., Koshiba T., Koshimizu K., Kuwahara S., Takahashi Y., Ogawa K., Yano M., Tokuda H., Nishino H., Mimaki Y., Sashida Y., Kitanaka S., Ohigashi H. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res. 60:2000;5059-5066.
15. Murakami A., Ohura S., Nakamura Y., Koshimizu K., Ohigashi H. 1′-Acetoxychavicol acetate, a superoxide anion generation inhibitor, potently inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in ICR mouse skin. Oncology. 53:1996;386-391.
16. Tanaka T., Kawabata K., Kakumoto M., Makita H., Matsunaga K., Mori H., Satoh K., Hara A., Murakami A., Koshimizu K., Ohigashi H. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor 1′-acetoxychavicol acetate. Jpn. J. Cancer Res. 88:1997;821-830.
17. Tanaka T., Makita H., Kawamori T., Kawabata K., Mori H., Murakami A., Satoh K., Hara A., Ohigashi H., Koshimizu K. A xanthineoxidase inhibitor 1′-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis. 18:1997;1113-1118.
18. Kobayashi Y., Nakae D., Akai H., Kishida H., Okajima E., Kitayama W., Denda A., Tsujiuchi T., Murakami A., Koshimizu K., Ohigashi H., Konishi Y. Prevention by 1′-acetoxychavicol acetate of the induction but not growth of putative preneoplastic, glutathione S-transferase placental form-positive, focal lesions in the livers of rats fed a choline-deficient, L-amino acid-defined diet. Carcinogenesis. 19:1998;1809-1814.
19. Kawabata K., Tanaka T., Yamamoto T., Ushida J., Hara A., Murakami A., Koshimizu K., Ohigashi H., Stoner S.D., Mori H. Suppression of N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis by dietary feeding of 1′-acetoxychavicol acetate. Jpn. J. Cancer Res. 91:2000;148-155.
20. Miyauchi M., Nishikawa A., Furukawa F., Nakamura H., Son H.-Y., Murakami A., Koshimizu K., Ohigashi H., Hirose M. Inhibitory effects of 1′-acetoxychavicol acetate on N-nitrosobis(2-oxopropyl)-amine-induced initiation of cholangiocarcinogenesis in Syrian hamsters. Jpn. J. Cancer Res. 91:2000;477-481.
21. Tanaka T., Shimizu M., Kohno H., Yoshitani S., Tsukio Y., Murakami A., Safitri R., Takahashi D., Yamamoto K., Koshimizu K., Ohigashi H., Mori H. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. Life Sci. 69:2001;1935-1945.
22. Hecht S.S., Kenney P.M., Wang M., Trushin N., Upadhyaya P. Effects of phenethyl isothiocyanate and benzyl isothiocyanate, individually and in combination, on lung tumorigenesis induced in A/J mice by benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Lett. 150:2000;49-56.
23. Sugie S., Okamoto K., Okumura A., Tanaka T., Mori H. Inhibitory effects of benzyl thiocyanate and benzyl isothiocyanate on methylazoxymethanol acetate-induced intestinal carcinogenesis in rats. Carcinogenesis. 15:1994;1555-1560.
24. Sugie S., Okumura A., Tanaka T., Mori H. Inhibitory effects of benzyl isothiocyanate and benzyl thiocyanate on diethylnitrosamine-induced hepatocarcinogenesis in rats. Jpn. J. Cancer Res. 84:1993;865-870.
25. Hirose M., Yamaguchi T., Kimoto N., Ogawa K., Futakuchi M., Sano M., Shirai T. Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats. Int. J. Cancer. 77:1998;773-777.
26. Ino N., Sugie S., Ohnishi M., Mori H. Lack of inhibitory effect of benzyl isothiocyanate on 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in rats. J. Toxicol. Sci. 21:1996;189-194.
27. Tanaka T., Kawabata K., Kakumoto M., Makita H., Hara A., Mori H., Satoh K., Murakami A., Kuki W., Takahashi Y., Yonei H., Koshimizu K., Ohigashi H. Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in F344 rats. Carcinogenesis. 18:1997;2155-2161.
28. Tanaka T., Kawabata K., Kakumoto M., Hara A., Murakami A., Kuki W., Takahashi Y., Yonei H., Maeda M., Ota T., Odashima S., Yamane T., Koshimizu K., Ohigashi H. Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Res. 58:1998;2550-2556.
29. T. Tanaka, K. Kawabata, M. Kakumoto, K. Matsunaga, H. Mori, A. Murakami, W. Kuki, Y. Takahashi, H. Yonei, K. Satoh, A. Hara, M. Maeda, T. Ota, S. Odashima, K. Koshimizu, H. Ohigashi, Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats, Carcinogenesis 19 (1998) 425-431.
30. Kawabata K., Tanaka T., Yamamoto T., Hara A., Murakami A., Koshimizu K., Ohigashi H., Stoner G.D., Mori H. Suppression of N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis by dietary feeding of auraptene. J. Exp. Clin. Cancer Res. 19:2000;45-52.
31. Kohno H., Yoshitani S., Tsukio Y., Murakami A., Koshimizu K., Yano M., Tokuda H., Nishino H., Ohigashi H., Tanaka T. Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Life Sci. 69:2001;901-913.
32. Murrill W.B., Brown N.M., Zhang J.X., Manzolillo P.A., Barnes S., Lamartiniere C.A. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis. 17:1996;1451-1457.
33. Lamartiniere C.A., Cotroneo M.S., Writz F.A., Wang J., Mentor-Marcel R., Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J. Nutr. 132:2002;552S-558S.
34. Rao C.V., Wang C.X., Simi B., Lubet R., Kelloff G., Steele V., Reddy B.S. Enhancement of experimental colon cancer by genistein. Cancer Res. 57:1997;3717-3722.
35. Bhat K.P., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Ann. NY Acad. Sci. 957:2002;210-229.
36. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
37. Ohata T., Fukuda K., Murakami A., Ohigashi H., Sugimura T., Wakabayashi K. Inhibition by 1′-acetoxychavicol acetate of lipopolysaccharide- and interferon-γ-induced nitric oxide production in RAW264 cells. Carcinogenesis. 19:1998;1007-1012.
38. Heiss E., Herhaus C., Klimo K., Bartsch H., Gerhauser C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 276:2001;32008-32015.
39. Doi M., Shichiri M., Katsuyama K., Ishimaru S., Hirata Y. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells. Atherosclerosis. 160:2002;123-132.
40. Tago K., Funakoshi M., Mano H., Yanagisawa K., Hayakawa M., Kuroiwa K., Iwahana H., Kasahara T., Tominaga S. Presence of a genistein-responsive inhibitory mechanism on interleukin-1alpha-induced NF-kappaB activation. Eur. J. Biochem. 268:2001;6233-6526.
41. Holmes-McNary M., Baldwin A.S. Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res. 60:2000;3477-3483.
42. Murakami A., Takahashi D., Kinoshita T., Koshimizu K., Kim H.-W., Yoshihiro A., Nakamura Y., Jiwajinda S., Ohigashi H. Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the α,β-unsaturated carbonyl group is a prerequisite. Carcinogenesis. 23:2002;795-802.
43. Tanaka T., Shimizu M., Kohno H., Yoshitani S., Tsukio Y., Murakami A., Safitri R., Takahashi D., Yamamoto K., Koshimizu K., Ohigashi H., Mori H. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbe. Life Sci. 69:2001;1935-1945.
44. Murakami A., Nakamura Y., Tanaka T., Kawabata K., Takahashi D., Koshimizu K., Ohigashi H. Suppression by citrus auraptene of phorbol ester- and endotoxin-induced inflammatory responses: role of attenuation of leukocyte activation. Carcinogenesis. 21:2000;1843-1850.
45. Chinetti G., Griglio S., Antonucci M., Torra I.P., Delerive P., Majd Z., Fruchart J.C., Chapman J., Najib J., Staels B. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273:1998;25573-25580.
46. Ohta T., Elnemr A., Yamamoto M., Ninomiya I., Fushida S., Nishimura G.I., Fujimura T., Kitagawa H., Kayahara M., Shimizu K., Yi S., Miwa K. Thiazolidinedione a peroxisome proliferator-activated receptor-gamma ligand, modulates the E-cadherin/beta-catenin system in a human pancreatic cancer cell line, BxPC-3. Int. J. Oncol. 21:2002;37-42.
47. Iida K.T., Kawakami Y., Suzuki H., Sone H., Shimano H., Toyoshima H., Okuda Y., Yamada N. PPAR gamma ligands, troglitazone and pioglitazone, up-regulate expression of HMG-CoA synthase and HMG-CoA reductase gene in THP-1 macrophages. FEBS Lett. 520:2002;177-181.
48. Bernardo A., Levi G., Minghetti L. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12,14-prostaglandin J2 in the regulation of microglial functions. Eur. J. Neurosci. 12:2000;2215-2223.
49. Yu Y., Correll P.H., Vanden Heuvel J.P. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim. Biophys. Acta. 1581:2002;89-99.
50. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., Kliewer S.A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272:1997;3406-3410.
51. Heim M., Johnson J., Boess F., Bendik I., Weber P., Hunziker W., Fluhmann B. Phytanic acid, a natural peroxisome proliferator-activated receptor (PPAR) agonist, regulates glucose metabolism in rat primary hepatocytes. FASEB J. 16:2002;718-720.
52. Liang Y.C., Tsai S.H., Tsai D.C., Lin-Shiau S.Y., Lin J.K. Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett. 496:2000;12-18.
53. Kiemer A.K., Weber N.C., Vollmar A.M. Induction of IkappaB: atrial natriuretic peptide as a regulator of the NF-kappaB pathway. Biochem. Biophys. Res. Commun. 295:2002;1068-1076.